首页>Journal of thrombosis and thrombolysis>Clinical validation of AggreGuide A-100 ADP, a novel assay for assessing the antiplatelet effect of oral P2Y(12) antagonists
Clinical validation of AggreGuide A-100 ADP, a novel assay for assessing the antiplatelet effect of oral P2Y(12) antagonists
作者单位:Thrombodyne Inc, Salt Lake City, UT USA[1]Sinai Hosp Baltimore, Sinai Ctr Thrombosis Res & Drug Dev, Baltimore, MD 21215 USA[2]Aggredyne Inc, Houston, TX USA[3]Hikari Dx, San Diego, CA USA[4]PCS Houston LLC, Houston, TX USA[5]